相关实验视频

Updated: Jul 19, 2025

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
05:57

Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases

Published on: August 2, 2022

4.2K

来自挪威献血者的康复性血用于治疗COVID-19

Lise Sofie Haug Nissen-Meyer1, Tine Torsvik Steinsvåg2, Mona Høysæter Fenstad3

  • 1Seksjon for blodgivning, Avdeling for immunologi og transfusjonsmedisin, Oslo universitetssykehus.

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke
|August 17, 2023
PubMed
概括

COVID-19康复性血捐赠者的特征是,抗体水平随着时间的推移而下降. 抗体测试对于产生有效的血治疗是必不可少的,因为症状严重程度不能预测抗体反应.

更多相关视频

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma07:34

Enrichment of Astrocyte-Derived Extracellular Vesicles from Human Plasma

Published on: August 3, 2022

3.0K
Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies05:30

Author Spotlight: Advancing the Analysis of Plasma Extracellular Vesicle Proteome for Cardiovascular Biomarker Studies

Published on: January 31, 2025

502

相关概念视频

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.9K